Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Common Equity: 2012-2025

Historic Common Equity for Veracyte (VCYT) over the last 12 years, with Sep 2025 value amounting to $1.3 billion.

  • Veracyte's Common Equity rose 6.94% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 6.94%. This contributed to the annual value of $1.2 billion for FY2024, which is 12.63% up from last year.
  • Latest data reveals that Veracyte reported Common Equity of $1.3 billion as of Q3 2025, which was up 3.00% from $1.2 billion recorded in Q2 2025.
  • In the past 5 years, Veracyte's Common Equity ranged from a high of $1.3 billion in Q3 2025 and a low of $971.2 million during Q2 2021.
  • Over the past 3 years, Veracyte's median Common Equity value was $1.1 billion (recorded in 2024), while the average stood at $1.1 billion.
  • Its Common Equity has fluctuated over the past 5 years, first spiked by 329.45% in 2021, then dropped by 5.32% in 2022.
  • Veracyte's Common Equity (Quarterly) stood at $1.1 billion in 2021, then declined by 1.94% to $1.1 billion in 2022, then dropped by 2.89% to $1.0 billion in 2023, then grew by 12.63% to $1.2 billion in 2024, then climbed by 6.94% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q3 2025, $1.2 billion for Q2 2025, and $1.2 billion during Q1 2025.